These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 31732509)

  • 41. Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.
    Hoffman RM
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Kiyuna T; Tome Y; Murakami T; Kawaguchi K; Igarashi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Elliott I; Singh SR; Kanaya F; Eilber FC; Hoffman RM
    BMC Cancer; 2018 Aug; 18(1):840. PubMed ID: 30126369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Animal Model: Xenograft Mouse Models in Esophageal Adenocarcinoma.
    Hassan MS; von Holzen U
    Methods Mol Biol; 2018; 1756():151-164. PubMed ID: 29600368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-fat diet promotes tumor growth in the patient-derived orthotopic xenograft (PDOX) mouse model of ER positive endometrial cancer.
    Shen K; Shen D; Jin D; Zheng Y; Zhu Y; Zhao X; Zhang Z; Wang N; Chen H; Yang L
    Sci Rep; 2023 Oct; 13(1):16537. PubMed ID: 37783734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice.
    Kageyama K; Ozaki S; Sato T
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-derived orthotopic xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model.
    Hiroshima Y; Zhang Y; Zhang N; Uehara F; Maawy A; Murakami T; Mii S; Yamamoto M; Miwa S; Yano S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    Anticancer Res; 2015 Feb; 35(2):697-701. PubMed ID: 25667448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.
    Zhang H; Qi L; Du Y; Huang LF; Braun FK; Kogiso M; Zhao Y; Li C; Lindsay H; Zhao S; Injac SG; Baxter PA; Su JM; Stephan C; Keller C; Heck KA; Harmanci A; Harmanci AO; Yang J; Klisch TJ; Li XN; Patel AJ
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of GFP-Expressing Imageable Mouse Models of Human Esophageal Squamous Cell Carcinoma Established in Various Anatomical Sites.
    Hu T; Qi H; Li P; Zhao G; Ma Y; Hao Q; Gao C; Zhang Y; Wang C; Yang M; Hoffman RM; Chen P; Dong Z
    Anticancer Res; 2015 Sep; 35(9):4655-63. PubMed ID: 26254355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model.
    Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Miwa S; Nelson SD; Dry SM; Li Y; Singh A; Kimura H; Hayashi K; Yamamoto N; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jan; 16(1):91-94. PubMed ID: 27830986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.
    Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL
    BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.
    Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K
    Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma.
    Zhang Z; Hu K; Kiyuna T; Miyake K; Kawaguchi K; Igarashi K; Nelson SD; Li Y; Singh SR; Hoffman RM
    Pharmacol Res; 2019 Apr; 142():169-175. PubMed ID: 30807865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
    Cox KE; Turner MA; Lwin TM; Amirfakhri S; Kelly KJ; Hosseini M; Ghosh P; Obonyo M; Hoffman RM; Yazaki PJ; Bouvet M
    Ann Surg Oncol; 2024 Sep; 31(9):6291-6299. PubMed ID: 38888861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation and multiomic profiling of a
    Zhao H; Cheng Y; Kalra A; Ma K; Zheng Y; Ziman B; Tressler C; Glunde K; Shin EJ; Ngamruengphong S; Khashab M; Singh V; Anders RA; Jit S; Wyhs N; Chen W; Li X; Lin DC; Meltzer SJ
    Sci Transl Med; 2022 Nov; 14(673):eabq6146. PubMed ID: 36449602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model.
    Kawaguchi K; Murakami T; Chmielowski B; Igarashi K; Kiyuna T; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
    Oncotarget; 2016 Nov; 7(44):71737-71743. PubMed ID: 27690220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Miyake K; Murakami T; Kiyuna T; Igarashi K; Kawaguchi K; Li Y; Singh AS; Dry SM; Eckardt MA; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Endo I; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Jan; 119(1):967-972. PubMed ID: 28681998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.